Devi Jaganathan
Overview
Explore the profile of Devi Jaganathan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sheikh S, Britt Jr R, Ryan-Wenger N, Khan A, Lewis B, Gushue C, et al.
Pediatr Pulmonol
. 2022 Nov;
58(3):825-833.
PMID: 36444736
Background: Cystic fibrosis (CF) is a multisystem disease with progressive deterioration. Recently, CF transmembrane conductance regulator (CFTR) modulator therapies were introduced that repair underlying protein defects. Objective of this study...
2.
Zhang S, Shrestha C, Robledo-Avila F, Jaganathan D, Wisniewski B, Brown N, et al.
Eur Respir J
. 2022 Oct;
61(4).
PMID: 36265882
Background: Abnormal macrophage function caused by dysfunctional cystic fibrosis transmembrane conductance regulator (CFTR) is a critical contributor to chronic airway infections and inflammation in people with cystic fibrosis (PWCF). Elexacaftor/tezacaftor/ivacaftor...
3.
Jaganathan D, Bruscia E, Kopp B
Int J Mol Sci
. 2022 Jul;
23(14).
PMID: 35887098
Cystic fibrosis (CF) is caused by mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Chronic inflammation and decline in lung function are major reasons for morbidity in CF....